Press release
Pulmonary Arterial Hypertension Market is Expected to reach US$5.19 bn by 2020
Pulmonary Arterial Hypertension (PAH) Market
Download Free exclusive Sample of this report:
http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1181
Pulmonary arterial hypertension is when the blood pressure inside the small arteries within the lungs increases. PAH can cause swelling of legs, fainting, dizziness, and shortness of breath, among other more serious symptoms. One of the biggest problems that a patient with PAH suffers is an extremely low tolerance to exercise. PAH can escalate into pulmonary vascular resistance and cause the failure of the right ventricle.
According to the report, the primary driver for the global PAH market is the list of newly-approved drugs and medical products aimed at treating PAH. A large number of medical products are already approved, while more are still in the pipeline. Another factor promoting the growth of the global PAH market is the increasing number of leaps taken in research and development efforts, aided by government policies and other initiatives.
The report provides a segmented analysis of the global PAH market. These segments are sorted within the categories of drug class and geography. The report also provides an extensive analysis of the pipeline drugs in the global PAH market.
In terms of drug class, the global PAH market is segmented into soluble guanylate cyclase (sGC) stimulators, phosphodiesterase-5 (PDE-5) inhibitors, endothelin receptor antagonists (ERAs), and prostacyclin and prostacyclin analogs. Of these, the report’s authors have put the prostacyclin and prostacyclin analogs segment ahead of the ERA segment, which means that the segment will lead the global PAH market by 2023, surpassing the current leader, ERAs.
The report’s geographical segmentation of the global PAH market reveals Asia Pacific to be the fastest-growing region for the given forecast period. The growth rate of this region is attributed to major opportunities that will be found in Australia, New Zealand, Japan, China, and India. Enterprises operating in these regions could take advantage of these opportunities and increase their profits and presence in the market.
The report, however, states one of the major restraints on the global PAH market as the challenges faced by the Rest of the World PAH market. The report’s study shows that most of the nations in the Rest of the World region possess a low level of awareness of this market’s products. Therefore, this region is showing a much slower growth rate when compared to the regions of North America or Europe.
Browse Research Report:
http://www.transparencymarketresearch.com/pulmonary-arterial-hypertension-therapeutics.html
The key players in the global pulmonary arterial hypertension market are United Therapeutics Corp., Novartis International AG, Pfizer Inc., GlaxoSmithKline plc, Bayer HealthCare, Gilead Sciences Inc., and Actelion Pharmaceuticals Ltd.
About Us
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We have an experienced team of Analysts, Researchers, and Consultants, who us e proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Contact
Transparency Market Research
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Pulmonary Arterial Hypertension Market is Expected to reach US$5.19 bn by 2020 here
News-ID: 356912 • Views: …
More Releases from TMR- Research Reports
Histone Methyltransferases Market by Global Industry Research 2019
Histones are the major protein constituents of eukaryotic nucleus. Histone methyltransferases catalyzes the transfer of methyl group to lysine and arginine residues of the histone protein. It catalyzes the reaction with the help of SN-2 mechanism where transfer of methyl group from S Adenosyl Methionine to amino group of target lysine takes place. There are seven histone methyltransferase includes EZ, SET1, SET2, SMYD, SUV39, SUV4-20 and RIZ. The main function…
Healthcare Mobility Solutions Market Advancements in Wireless Networks to Drive …
Focus on Reducing Healthcare Costs Drives Global Market
The constantly growing and evolving medical needs have been the driving force behind the evolution of healthcare mobility solutions. The aim of these solutions is to reduce the healthcare costs and to provide the patients an optimum solution in the least possible time. The simplicity of this objectivity has been successfully achieved by the development of healthcare mobility solutions’ products and services such…
Global District Heating and Cooling Market: Big Players Foraying into Manufactur …
To gauge the competitive dynamics in the global district heating and cooling (DHC) market, the DHC system manufacturers, project contractors, and plant operators in the supply chain will have to be factored in, states a report by Transparency Market Research (TMR). In the coming years, big plant operators and private operators are predicted to start manufacturing DHC systems, which in turn, would likely heat up the competition. Competition would also…
Condiment Sauces Market is Expected to Exhibit a positive CAGR of 3.2% from 2014 …
Condiment sauces are used in food to enhance taste, flavor or as a complimentary item in different dishes. It is used either as table dips or in cooking or as both. The condiments sauces market has experienced a diversified trends across different regions such as North America, Europe, Asia Pacific and RoW. The Global condiment sauces market is expected to witness rapid changes due to fast changing eating patterns across…
More Releases for PAH
Strategic Insights into the Pulmonary Arterial Hypertension (PAH) Market 2028
The global Pulmonary Arterial Hypertension (PAH) market was valued at USD 5.2 billion in 2020 and is anticipated to reach USD 13.5 billion by 2028, with a CAGR of 5.4% from 2021 to 2028.Research and development efforts, along with collaborative initiatives between healthcare professionals and governments, are propelling market growth amid the COVID-19 pandemic.Market stakeholders are focusing on effective and cost-efficient treatments for PAH patients, although lack of awareness regarding…
Pulmonary Arterial Hypertension (PAH) Market Trends and Forecast 2021-2028
Pulmonary Arterial Hypertension (PAH) Market: Overview
The pulmonary arterial hypertension (PAH) market is estimated to attain a valuation of US$ 13.5 Bn by the end of 2028, states a study by Transparency Market Research (TMR). Besides, the report notes that the market is prognosticated to expand at a CAGR of 5.4% from 2021 to 2028.
The key objective of the TMR report is to offer a complete assessment of the global market…
Development: Pulmonary Arterial Hypertension (PAH) Market Growth Analysis
The global pulmonary arterial hypertension (pah) market is estimated to surpass $9,670.2 million by 2027, exhibiting a CAGR of 5.8% from 2020 to 2027.
The report provides all-inclusive analysis of global pulmonary arterial hypertension (pah) market with comprehensive study of the various facets of the market including market dynamics, major segments and regions, top leading players, and competitive landscape.
Research Methodology
Research Dive offers its clients extensive research and analysis gleaned from wide…
Pulmonary Arterial Hypertension (PAH) Market Research and Clinical Analysis 2020
Global Pulmonary Arterial Hypertension (PAH) Market research report published by market insight reports explores the current outlook in global and key regions from the perspective of Major Players, Countries, Product types and end industries. This report analyzes top players in the global market, and divides the Market into several parameters.
This Pulmonary Arterial Hypertension (PAH) Market research report identifies the competitive landscape of industries to understand the competition at International level.…
Pulmonary Arterial Hypertension (PAH) Medicine Market (2020-2027) Report Offers …
The research study includes the latest updates about the COVID-19 impact on the Pulmonary Arterial Hypertension (PAH) Medicine sector. The outbreak has broadly influenced the global economic landscape. The report contains a complete breakdown of the current situation in the ever-evolving business sector and estimates the aftereffects of the outbreak on the overall economy.
The market research report on the global Pulmonary Arterial Hypertension (PAH) Medicine market provides an extensive and…
Global Pulmonary Arterial Hypertension (PAH) Medicine Sales Market Report 2017
MarketResearchReports.Biz presents this most up-to-date research on "Global Pulmonary Arterial Hypertension (PAH) Medicine Sales Market Report 2017"
Description
In this report, the global Pulmonary Arterial Hypertension (PAH) Medicine market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.
Geographically, this report split global into several key Regions, with sales (K MT),…
